Lock-Up Release Analysis: $23 Billion of Shares Set to Flood Markets
A significant amount of shares – worth approximately $23 billion – are scheduled to be released from restrictions (called “lock-ins”) by companies over the next few months. This analysis by Nuvama Institutional Equities looks at 101 companies expected to have these restrictions lifted between December 29, 2025, and March 2026. Understanding this release is crucial because it could impact stock prices.
Key Points
- 101 companies with $23 billion in shares will be released.
- Lock-ins expire between December 29, 2025, and March 2026.
- Promoters hold a large portion of these shares.
- Institutional investors may sell shares post-lock-up.
- Recent IPO activity fuels the increased lock-up expirations.
- Share price fluctuations are possible after release.
Which Companies Are Affected?
The release isn’t happening all at once. Some companies have short “lock-in” periods – just one month. For example, ICICI Prudential AMC, Meesho, and Nephrocare Health Services will see their restrictions lift within a month. Other companies have longer periods, like three or six months.
What Happens With the Shares?
An analyst, Ambareesh Baliga, explained that many of these shares will likely be sold once the lock-in period ends. This is because many of these companies had initial public offerings (IPOs) recently. Investors who bought shares when they first became available may want to sell them now that the restrictions are lifted. These shares are often held by big investors like pension funds and wealthy individuals.
The impending release of these shares highlights the potential for significant market activity and price adjustments.
